Literature DB >> 20591914

E-cadherin immunoexpression patterns in the characterisation of gastric carcinoma histotypes.

P R Almeida1, V A Ferreira, C C Santos, F D Rocha-Filho, R R Feitosa, E A A Falcão, B K Cavada, R A Ribeiro.   

Abstract

AIMS: E-cadherin, the main epithelial intercellular adhesion molecule, is abnormally expressed in many cancer types, including gastric carcinoma, which is the second leading cause of cancer death worldwide. The aim of this study was to contribute to the characterisation of gastric carcinoma histotypes based on a new approach to E-cadherin immunoexpression.
METHODS: 97 gastric tumour samples obtained from the files of the Hospital of Cancer/Cancer Institute of Ceará, Brazil, were histologically analysed and classified as intestinal (n=40), diffuse (n=34), mixed (n=16) or unclassified (n=7) carcinomas. Immunohistochemistry was performed on the tissue microarray sections. Scores were applied according to the system of Jawhari: 0, no staining; 1, cytoplasmic staining; 2, cytoplasmic and membranous staining in the same case; 3, normal membranous immunoexpression; abnormal patterns: scores 0, 1 and 2; normal pattern: score 3. Jawhari scores were then evaluated utilising another approach: the absence of membranous expression scores (0 and 1) versus the presence of membranous expression (scores 2 and 3).
RESULTS: A significant association between membranous expression of E-cadherin and the intestinal histotype (36/40 (90%), and 28/41 (68%) for other histotypes) was found, while diffuse carcinomas were related to the absence of membranous expression. A very strong and peculiar relationship was observed between cytoplasm-exclusive E-cadherin expression (score 1) and the diffuse component of mixed tumours (11/16 (69%)).
CONCLUSIONS: E-cadherin immunoexpression patterns help us to characterise gastric carcinoma histotypes. The presence or absence of membranous staining is the most valuable criterion in evaluating E-cadherin expression. Mixed tumours show a characteristic E-cadherin cytoplasmic expression in gastric carcinomas.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20591914     DOI: 10.1136/jcp.2010.076026

Source DB:  PubMed          Journal:  J Clin Pathol        ISSN: 0021-9746            Impact factor:   3.411


  8 in total

1.  Overexpression of EphA2 correlates with epithelial-mesenchymal transition-related proteins in gastric cancer and their prognostic importance for postoperative patients.

Authors:  Futao Hou; Weijie Yuan; Jin Huang; Liyuan Qian; Zhikang Chen; Jie Ge; Shaobin Wu; Jinxiang Chen; Jixu Wang; Zihua Chen
Journal:  Med Oncol       Date:  2011-12-22       Impact factor: 3.064

2.  Anti-cancer effects of novel flavonoid vicenin-2 as a single agent and in synergistic combination with docetaxel in prostate cancer.

Authors:  Lokesh Dalasanur Nagaprashantha; Rit Vatsyayan; Jyotsana Singhal; Spence Fast; Rhonda Roby; Sanjay Awasthi; Sharad S Singhal
Journal:  Biochem Pharmacol       Date:  2011-07-23       Impact factor: 5.858

3.  Gastric tumor development in Smad3-deficient mice initiates from forestomach/glandular transition zone along the lesser curvature.

Authors:  Ki Taek Nam; Ryan O'Neal; Yeo Song Lee; Yong Chan Lee; Robert J Coffey; James R Goldenring
Journal:  Lab Invest       Date:  2012-03-12       Impact factor: 5.662

4.  A novel CDH1 germline missense mutation in a sporadic gastric cancer patient in north-east of Italy.

Authors:  Marica Garziera; Valli De Re; Silvano Geremia; Raquel Seruca; Joana Figueiredo; Soraia Melo; Joana Simões-Correia; Laura Caggiari; Mariangela De Zorzi; Vincenzo Canzonieri; Renato Cannizzaro; Giuseppe Toffoli
Journal:  Clin Exp Med       Date:  2012-04-29       Impact factor: 3.984

5.  2'-hydroxyflavanone inhibits proliferation, tumor vascularization and promotes normal differentiation in VHL-mutant renal cell carcinoma.

Authors:  Lokesh Dalasanur Nagaprashantha; Rit Vatsyayan; Jyotsana Singhal; Poorna Lelsani; Laszlo Prokai; Sanjay Awasthi; Sharad S Singhal
Journal:  Carcinogenesis       Date:  2011-02-08       Impact factor: 4.944

6.  Research and clinical applications of molecular biomarkers in gastrointestinal carcinoma (Review).

Authors:  Feng Jiao; Ziliang Jin; Lei Wang; Liwei Wang
Journal:  Biomed Rep       Date:  2013-08-20

7.  E-cadherin Expression in Canine Gastric Carcinomas: Association with Clinicopathological Parameters.

Authors:  Ana R Flores; Alexandra Rêma; João R Mesquita; Marian Taulescu; Fernanda Seixas; Fátima Gärtner; Irina Amorim
Journal:  Vet Sci       Date:  2022-04-01

8.  Aberrant methylation of PCDH10 and RASSF1A genes in blood samples for non-invasive diagnosis and prognostic assessment of gastric cancer.

Authors:  Charinya Pimson; Tipaya Ekalaksananan; Chamsai Pientong; Supannee Promthet; Nuntiput Putthanachote; Krittika Suwanrungruang; Surapon Wiangnon
Journal:  PeerJ       Date:  2016-06-09       Impact factor: 2.984

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.